Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results ...Middle East

PR Newswire - News
Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
Actively recruiting clinical trials in neurology and rheumatology with KYV-101 No severe ICANS or CRS reported in first 36 autoimmune disease patients treated with KYV-101 Received FDA RMAT Designation for KYV-101 for treatment of patients with Stiff-Person Syndrome Received FDA RMAT...

Hence then, the article about kyverna therapeutics provides business update and reports second quarter 2024 financial results was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News